The main findings were that patients with NAFLD and patients with cirrhosis exhibit the following: (1) hyperinsulinemia, hyperglucagonemia, and impaired glucose tolerance due to decreased insulin sensitivity, (2) exaggeration of these metabolic disturbances postprandially, and 3. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.